O88.211 Thromboembolism in pregnancy, first trimester

Name of the Condition

• Thromboembolism in pregnancy, first trimester

Summary

Thromboembolism in pregnancy, first trimester, refers to the formation or migration of blood clots (thrombi) within the venous or arterial system during the first 13 weeks of pregnancy. This condition can lead to serious complications, including pulmonary embolism or deep vein thrombosis, and requires prompt evaluation and management due to the increased risk of maternal morbidity.

Causes

Thromboembolism in pregnancy is typically caused by a combination of hypercoagulability, venous stasis, and vascular injury, which are exacerbated by pregnancy-related physiological changes. These changes include increased clotting factors, reduced fibrinolysis, and compression of pelvic veins by the growing uterus. Additional triggers may include trauma, surgery, or underlying thrombophilic disorders.

Risk Factors

• Personal or family history of venous thromboembolism (VTE).
• Thrombophilia (e.g., factor V Leiden, antiphospholipid syndrome).
• Prolonged immobility or bed rest.
• Obesity or advanced maternal age.
• Multiple gestation or prior cesarean delivery.
• Use of assisted reproductive technology.

Symptoms

• Unilateral leg swelling, pain, or tenderness (deep vein thrombosis).
• Sudden onset of dyspnea, chest pain, or cough (pulmonary embolism).
• Tachycardia, hypotension, or syncope.
• Calf pain or warmth (DVT signs).
• Hemoptysis or pleuritic chest pain (PE signs).

Diagnosis

Diagnosis involves clinical assessment, imaging (e.g., Doppler ultrasound for DVT, CT pulmonary angiography for PE), and laboratory tests (e.g., D-dimer, coagulation studies). A high index of suspicion is critical, as symptoms may mimic other pregnancy-related conditions. Imaging is guided by risk stratification and clinical findings.

Treatment Options

Treatment typically includes anticoagulation (e.g., low-molecular-weight heparin) to prevent clot extension or recurrence. Therapeutic doses are adjusted for pregnancy safety. In severe cases, thrombolytic therapy or inferior vena cava filter placement may be considered. Close monitoring of maternal and fetal status is essential.

Prognosis and Follow-Up

With timely treatment, outcomes are generally favorable, but complications like post-thrombotic syndrome or recurrent VTE may occur. Follow-up includes ongoing anticoagulation management, periodic risk reassessment, and monitoring for bleeding or fetal well-being. Long-term prophylaxis may be recommended for high-risk patients.

Complications

• Pulmonary embolism (life-threatening if untreated).
• Deep vein thrombosis progression or recurrence.
• Post-thrombotic syndrome (chronic leg pain/swelling).
• Maternal or fetal morbidity from anticoagulation (e.g., bleeding, placental abruption).

Lifestyle & Prevention

• Maintain regular physical activity (e.g., walking) to promote circulation.
• Stay hydrated and avoid prolonged sitting/standing.
• Use compression stockings if recommended.
• Manage weight and address modifiable risk factors (e.g., smoking cessation).
• Follow provider guidance on anticoagulation or prophylaxis.

When to Seek Professional Help

Seek immediate care for sudden chest pain, shortness of breath, or leg swelling. Contact a provider for persistent calf pain, unexplained tachycardia, or signs of bleeding (e.g., bruising, hematuria) while on anticoagulants. Early evaluation reduces complications.

Tips for Medical Coders

Document the trimester (first trimester) and confirm the thromboembolic event (e.g., DVT, PE) to support code O88.211. Include details on risk factors, diagnostic methods, and treatment to clarify clinical context. Ensure documentation aligns with ICD-10-CM guidelines for obstetric thromboembolism.